Kyoto, Japan

Tetsuo Shibata

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Shibata. Retrieved from https://idiyas.com/inventor/tetsuo-shibata-iy51saq1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tetsuo Shibata: A Pioneer in Quinolinecarboxylic Acid Derivatives

Introduction: Tetsuo Shibata, an inventive mind based in Kyoto, Japan, has made significant contributions to the field of pharmaceuticals. His expertise lies in developing unique chemical derivatives that demonstrate valuable properties for various applications.

Latest Patents: Shibata holds one notable patent, focusing on quinolinecarboxylic acid derivatives and their salts. This innovation may have far-reaching implications in medicinal chemistry, potentially impacting drug formulations and therapeutic applications.

Career Highlights: Currently, Tetsuo Shibata is employed at Kaken Pharmaceutical Company, Ltd., where his research and inventive spirit drive the development of key pharmaceutical innovations. His work at Kaken Pharmaceutical has further solidified his reputation as a knowledgeable inventor in his field.

Collaborations: Collaborating closely with talented colleagues such as Jun Nakano and Hideto Fukui, Shibata contributes to a dynamic team at Kaken Pharmaceutical. Their collective expertise enhances the company's innovative capabilities and fosters a productive research environment.

Conclusion: Tetsuo Shibata stands as a testament to the power of innovation in the pharmaceutical industry. His dedication to advancing knowledge in quinolinecarboxylic acid derivatives positions him as a valuable inventor and an asset to Kaken Pharmaceutical Company, Ltd. With continued collaboration and research, he is sure to lead further breakthroughs in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…